Literature DB >> 2457096

Action of antibodies directed against the acetylcholine receptor on channel function at mouse and rat motor end-plates.

J O Dolly1, M Gwilt, G Lacey, J Newsom-Davis, A Vincent, P Whiting, D W Wray.   

Abstract

1. The acute effects of antibodies (both polyclonal and monoclonal) raised against the acetylcholine receptor were studied at mouse and rat end-plates. Isolated muscles were incubated in solutions containing antibody for 2 1/4 to 3 1/2 h. Intracellular microelectrode techniques were then used to record miniature end-plate potentials (MEPPs) and voltage noise. 2. Most antibody preparations investigated did not reduce MEPP amplitudes as compared with controls. One monoclonal (C7) and one polyclonal (J) preparation irreversibly reduced MEPP amplitudes. Both preparations caused reductions in acetylcholine-induced depolarization and associated channel opening frequency (from voltage noise analysis). Single-channel depolarization was not altered by these antibodies. 3. On the basis of these and previous results, four antibody binding regions on the receptor surface were distinguished according to whether channel function and/or alpha-bungarotoxin binding were affected. Although most antibody preparations did not affect channel function, monoclonal antibody C7 appeared to alter function by acting on the channel itself so as to prevent channel opening.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457096      PMCID: PMC1191681          DOI: 10.1113/jphysiol.1988.sp017097

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  38 in total

1.  Serum factor blocks neuromuscular transmission in myasthenia gravis: electrophysiologic study with intracellular microelectrodes.

Authors:  N Shibuya; K Mori; Y Nakazawa
Journal:  Neurology       Date:  1978-08       Impact factor: 9.910

2.  Effects of normal and myasthenic serum factors on innervated and chronically denervated mammalian muscles.

Authors:  E X Albuquerque; F J Lebeda; S H Appel; R Almon; F C Kauffman; R F Mayer; T Narahashi; J Z Yeh
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

3.  Myasthenia gravis serum reduces acetylcholine sensitivity in cultured rat myotubes.

Authors:  R Anwyl; S M Appel; T Narahashi
Journal:  Nature       Date:  1977-05-19       Impact factor: 49.962

Review 4.  Acetylcholine receptor and myasthenia gravis.

Authors:  B W Fulpius; A D Zurn; D A Granato; R M Leder
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

5.  Reduction of acetylcholine sensitivity of chick muscle in culture by myasthenia gravis serum.

Authors:  A L Harvey; J G Robertson; T Barkas; R Harrison; G G Lunt; F A Stephenson; M J Campbell; R H Teague
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

6.  Acetylcholine-induced conductance fluctuations in cultured human myotubes.

Authors:  S Bevan; R W Kullberg; J Rice
Journal:  Nature       Date:  1978-06-08       Impact factor: 49.962

7.  Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue culture.

Authors:  S Bevan; R W Kullberg; S F Heinemann
Journal:  Nature       Date:  1977-05-19       Impact factor: 49.962

8.  Modulation of acetylcholine receptor by antibody against the receptor.

Authors:  S Heinemann; S Bevan; R Kullberg; J Lindstrom; J Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

9.  A monoclonal antibody interfering with binding and response of the acetylcholine receptor.

Authors:  G Fels; R Plümer-Wilk; M Schreiber; A Maelicke
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

10.  The statistical nature of the acetycholine potential and its molecular components.

Authors:  B Katz; R Miledi
Journal:  J Physiol       Date:  1972-08       Impact factor: 5.182

View more
  1 in total

1.  Effects of a monoclonal anti-acetylcholine receptor antibody on the avian end-plate.

Authors:  R A Maselli; D J Nelson; D P Richman
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.